MII IG Kerndatensatz-Modul Molekulares Tumorboard
2026.0.0 - release Unknown region code '276'

MII IG Kerndatensatz-Modul Molekulares Tumorboard, published by Medizininformatik-Initiative. This guide is not an authorized publication; it is the continuous build for version 2026.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/medizininformatik-initiative/kerndatensatzmodul-molekulares-tumorboard/ and changes regularly. See the Directory of published versions

: 07.08.2023 Z3 Mirvetuximab soravtansine 6mg/kg KG, Wdh d22 - XML Representation

Raw xml | Download


<MedicationStatement xmlns="http://hl7.org/fhir">
  <id value="MII-EXA-MTB-Systemische-Therapie-Medication-3"/>
  <meta>
    <profile
             value="https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-pr-mtb-systemtherapie-medication-statement"/>
    <profile
             value="https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-pr-mtb-systemische-therapie-medication-statement|2026.0.0"/>
  </meta>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: MedicationStatement MII-EXA-MTB-Systemische-Therapie-Medication-3</b></p><a name="MII-EXA-MTB-Systemische-Therapie-Medication-3"> </a><a name="hcMII-EXA-MTB-Systemische-Therapie-Medication-3"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profiles: <a href="StructureDefinition-mii-pr-mtb-systemtherapie-medication-statement.html">MII PR MTB Systemtherapie Medication Statement</a>, <a href="https://simplifier.net/resolve?scope=de.basisprofil.r4@1.5.4&amp;canonical=https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-pr-mtb-systemische-therapie-medication-statement|2026.0.0">https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-pr-mtb-systemische-therapie-medication-statement|2026.0.0</a></p></div><p><b>basedOn</b>: <a href="MedicationRequest-mii-exa-mtb-medication-request-mirvetuximab.html">MedicationRequest: extension = 1,m1A,http://doi.org#10.1200/JCO.2022.40.16_suppl.5512,http://www.ncbi.nlm.nih.gov/pubmed#38055253; status = completed; intent = proposal; medication[x] = MIRVETUXIMAB SORAVTANSINE; authoredOn = 2023-03-28</a></p><p><b>partOf</b>: <a href="Procedure-MII-EXA-MTB-Systemische-Therapie-1.html">Procedure Zytostatische Chemotherapie, Immuntherapie und antiretrovirale Therapie</a></p><p><b>status</b>: Completed</p><p><b>statusReason</b>: <span title="Codes:">E</span></p><p><b>medication</b>: <span title="Codes:{http://fdasis.nlm.nih.gov 98DE7VN88D}, {http://fhir.de/CodeSystem/bfarm/atc L01FX26}">MIRVETUXIMAB SORAVTANSINE</span></p><p><b>subject</b>: <a href="Patient-PatientKimMusterperson.html">Kim Musterperson  (no stated gender), DoB: 1956-03-14</a></p><p><b>effective</b>: 2023-08-07 --&gt; 2023-08-07</p><p><b>note</b>: </p><blockquote><div><p>07.08.2023 Z3 Mirvetuximab soravtansine 6mg/kg KG, Wdh d22</p>
</div></blockquote><blockquote><p><b>dosage</b></p><h3>DoseAndRates</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Dose[x]</b></td></tr><tr><td style="display: none">*</td><td>6 mg/kg KG<span style="background: LightGoldenRodYellow"> (Details: UCUM  codemg/kg{KG} = 'mg/kg{KG}')</span></td></tr></table></blockquote></div>
  </text>
  <basedOn>🔗 
    <reference
               value="MedicationRequest/mii-exa-mtb-medication-request-mirvetuximab"/>
  </basedOn>
  <partOf>🔗 
    <reference value="Procedure/MII-EXA-MTB-Systemische-Therapie-1"/>
  </partOf>
  <status value="completed"/>
  <statusReason>
    <coding>
      <code value="E"/>
    </coding>
  </statusReason>
  <medicationCodeableConcept>
    <coding>
      <system value="http://fdasis.nlm.nih.gov"/>
      <code value="98DE7VN88D"/>
      <display value="MIRVETUXIMAB SORAVTANSINE"/>
    </coding>
    <coding>
      <system value="http://fhir.de/CodeSystem/bfarm/atc"/>
      <version value="2025"/>
      <code value="L01FX26"/>
      <display value="Mirvetuximab soravtansin"/>
    </coding>
  </medicationCodeableConcept>
  <subject>🔗 
    <reference value="Patient/PatientKimMusterperson"/>
  </subject>
  <effectivePeriod>
    <start value="2023-08-07"/>
    <end value="2023-08-07"/>
  </effectivePeriod>
  <note>
    <text value="07.08.2023 Z3 Mirvetuximab soravtansine 6mg/kg KG, Wdh d22"/>
  </note>
  <dosage>
    <doseAndRate>
      <doseQuantity>
        <value value="6"/>
        <unit value="mg/kg KG"/>
        <system value="http://unitsofmeasure.org"/>
        <code value="mg/kg{KG}"/>
      </doseQuantity>
    </doseAndRate>
  </dosage>
</MedicationStatement>